BioSpace News Archive

Theratechnologies Inc. today reported business highlights and financial results for the first quarter of fiscal year 2022 ended February 28, 2022 (Q1 2022).

Vibrant announced today that an abstract titled, “Efficacy and Safety of Vibrant® Capsule for Chronic Idiopathic Constipation (CIC): Randomized, Double-Blind, Multicenter, Placebo-Controlled, Phase III Trial” has been accepted for an abstract presentation at the 2022 Digestive Disease Week Conference (DDW 2022).

Appili Therapeutics Inc. today announced the addition of ATI-1801, a clinical stage topical paromomycin product to treat cutaneous leishmaniasis, to its development pipeline.

Arch Therapeutics, Inc., a marketer and developer of novel self-assembling wound care and biosurgical devices, announced that two clinical case reports on the use of AC5® Advanced Wound System were presented as Poster Presentations and three additional cases were presented during a live Open Air Studio session at the 2022 Symposium on Advanced Wound Care Spring.

Praxis Precision Medicines, Inc. announced that the Company will host an Epilepsy Day from 8:30 a.m. to 11:30 a.m. ET on Wednesday, April 27, 2022 virtually and in New York City.

aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that the U.S. Food and Drug Administration (FDA) has granted the company orphan drug designation for its lead therapeutic candidate, efzofitimod, for the treatment of systemic sclerosis (SSc, also known as scleroderma).

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the celebration of a milestone moment for BOTOX® Cosmetic (onabotulinumtoxinA). April 15, 2022, will mark 20 years since the U.S. Food and Drug Administration (FDA) first approved the product to temporarily improve the look of moderate to severe glabellar lines, located between your eyebrows.

Today, Versant Ventures announced the debut of Cimeio Therapeutics, a biotechnology company developing a novel approach to cell therapies.

Today, Alio Inc., announced it received FDA 510(k) clearance for its remote monitoring system intended for use by healthcare professionals to intermittently collect physiological data in home use settings.

Freenome announced its co-authorship of a study with Merck KGaA, Darmstadt Germany, a leading science and technology company.